IMPROVING HEALTH & PERFORMANCE
We are a Swiss-Spanish Neuro Technology firm that creates non-invasive neurostimulation smart solutions to improve current therapies and neurostimulation approaches.
We bring neurostimulation closer to people
Xana technology combines pioneering therapeutic efficacy, monitoring capabilities and information management to maximize user experience and tailor treatments to confidently face the challenges that Health and Wellness will generate in the coming decade.
A new generation of clinically validated mobile devices, each with its own study, to be used anywhere and at any time.
We create solid, realistic and scalable
business models in a variety of wellness and medical fields
Our first product to
market has already
& STRESS RELIEF
Wireless earbud anatomically customized to each user includes miniaturized electronics to manage two electrodes and one biosensor. They are easily controlled by the native App that is connected to intelligent cloud systems ready to gather and organize all the data needed to customize each treatment.
Able to manage mechanisms of action
experienced & specialized
team and advisory board
Dr. Miguel López PhD
Co-Founder, CEO & Head of Science
Co-Founder & Head of Innovation
Head of Finance
Dr. David Calvo MD, PhD
Dr.Joaquín Azpilicueta MD
Managing Director Switzerland
Alberto Farré Head of Electronics
Iván Cortina Audiology Research
Extensive executive and international business development expertise in pharma, medical technology and multinational service corporations.
XANA Co-Founder. UCB Pharma Medical Director (Belgium)
Dr. Iñaki G. Gurtubay
Head of Neurophysiology. University Hospital of Navarra (Spain)
Dr. José Antonio Vega
MD, PhD Professor of Anatomy. University of Oviedo (Spain)
Dr. Gonzalo París
PhD Glaxomithkline Former & Scientific Director
Xana has accumulated the required skills and experience to create and execute a robust and scalable business strategy to maximize the potential of Neurostimulation